secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2025-04-11T23:59:59+00:00
Accession:  0001641172-25-003741
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed subsidiary Lucid Diagnostics closes 14.4M share offering raising ~$16.1M net
--------------------------------------------------------------------------------

- Lucid Diagnostics closed sale of 14,375,000 shares at $1.20 each, including full exercise of underwriters' option.
- Net proceeds expected to be approximately $16.1 million after underwriting discounts and expenses.
- Proceeds will be used for working capital and general corporate purposes.
- Offering was made under Lucid's existing shelf registration statement (Form S-3) and prospectus supplement dated April 9, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000164117225003741/0001641172-25-003741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000164117225003741/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-003741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer